Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 544 Thousand CAD | -35.92% |
| 2022 | 849 Thousand CAD | -27.37% |
| 2021 | 1.16 Million CAD | -19.21% |
| 2020 | 1.44 Million CAD | 32.87% |
| 2019 | 1.08 Million CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 72.77 Million CAD | 1615.38% |
| 2015 | 4.24 Million CAD | -13.07% |
| 2014 | 4.88 Million CAD | 0.0% |
| 2012 | 4.78 Million CAD | 2.89% |
| 2011 | 4.64 Million CAD | -79.31% |
| 2010 | 22.46 Million CAD | -6.92% |
| 2009 | 24.14 Million CAD | -3.6% |
| 2008 | 25.04 Million CAD | -26.75% |
| 2007 | 34.18 Million CAD | 101.78% |
| 2006 | 16.94 Million CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 476 Thousand CAD | -12.5% |
| 2024 Q2 | 402 Thousand CAD | -15.55% |
| 2023 Q4 | 544 Thousand CAD | -13.1% |
| 2023 Q2 | 694 Thousand CAD | -10.68% |
| 2023 FY | 544 Thousand CAD | -35.92% |
| 2023 Q3 | 626 Thousand CAD | -9.8% |
| 2023 Q1 | 777 Thousand CAD | -8.48% |
| 2022 Q3 | 988 Thousand CAD | -2.76% |
| 2022 Q4 | 849 Thousand CAD | -14.07% |
| 2022 FY | 849 Thousand CAD | -27.37% |
| 2022 Q1 | 1.09 Million CAD | -6.76% |
| 2022 Q2 | 1.01 Million CAD | -6.79% |
| 2021 Q3 | 1.23 Million CAD | -4.4% |
| 2021 Q1 | 1.37 Million CAD | -5.25% |
| 2021 Q4 | 1.16 Million CAD | -5.5% |
| 2021 FY | 1.16 Million CAD | -19.21% |
| 2021 Q2 | 1.29 Million CAD | -5.62% |
| 2020 Q2 | 995 Thousand CAD | -4.51% |
| 2020 FY | 1.44 Million CAD | 32.87% |
| 2020 Q3 | 947 Thousand CAD | -4.82% |
| 2020 Q1 | 1.04 Million CAD | -4.32% |
| 2020 Q4 | 1.44 Million CAD | 52.8% |
| 2019 FY | 1.08 Million CAD | 0.0% |
| 2019 Q2 | 525 Thousand CAD | -12.65% |
| 2019 Q3 | 451 Thousand CAD | -14.1% |
| 2019 Q1 | 601 Thousand CAD | 0.0% |
| 2019 Q4 | 1.08 Million CAD | 141.46% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q4 | - CAD | -100.0% |
| 2017 Q3 | 57.19 Million CAD | -5.06% |
| 2017 Q2 | 60.24 Million CAD | -0.3% |
| 2017 Q1 | 60.42 Million CAD | -16.98% |
| 2016 FY | 72.77 Million CAD | 1615.38% |
| 2016 Q2 | 3.43 Million CAD | -10.58% |
| 2016 Q1 | 3.83 Million CAD | -9.55% |
| 2016 Q3 | 3.02 Million CAD | -11.87% |
| 2016 Q4 | 72.77 Million CAD | 2306.46% |
| 2015 Q4 | 4.24 Million CAD | -8.69% |
| 2015 Q1 | 4.89 Million CAD | 0.0% |
| 2015 Q3 | 4.64 Million CAD | -5.37% |
| 2015 FY | 4.24 Million CAD | -13.07% |
| 2015 Q2 | 4.9 Million CAD | 0.3% |
| 2014 FY | 4.88 Million CAD | 0.0% |
| 2014 Q1 | 4.83 Million CAD | 0.3% |
| 2014 Q2 | 4.84 Million CAD | 0.34% |
| 2014 Q3 | 4.86 Million CAD | 0.3% |
| 2013 Q1 | 4.74 Million CAD | -9.93% |
| 2013 Q2 | 4.78 Million CAD | 0.71% |
| 2013 Q3 | 4.8 Million CAD | 0.44% |
| 2013 Q4 | 4.81 Million CAD | 0.28% |
| 2012 Q2 | 4.64 Million CAD | -3.15% |
| 2012 FY | 4.78 Million CAD | 2.89% |
| 2012 Q4 | 5.27 Million CAD | 0.84% |
| 2012 Q3 | 5.22 Million CAD | 12.47% |
| 2012 Q1 | 4.79 Million CAD | 4.73% |
| 2011 FY | 4.64 Million CAD | -79.31% |
| 2011 Q4 | 4.58 Million CAD | -16.22% |
| 2011 Q3 | 5.46 Million CAD | -75.66% |
| 2011 Q2 | 22.46 Million CAD | -0.33% |
| 2011 Q1 | 22.54 Million CAD | -5.13% |
| 2010 Q1 | 24.24 Million CAD | -0.27% |
| 2010 Q2 | 24.14 Million CAD | -0.43% |
| 2010 Q3 | 24.68 Million CAD | 2.24% |
| 2010 Q4 | 23.76 Million CAD | -3.73% |
| 2010 FY | 22.46 Million CAD | -6.92% |
| 2009 Q1 | 29.36 Million CAD | 3.17% |
| 2009 Q3 | 25.17 Million CAD | 0.52% |
| 2009 Q2 | 25.04 Million CAD | -14.71% |
| 2009 Q4 | 24.31 Million CAD | -3.42% |
| 2009 FY | 24.14 Million CAD | -3.6% |
| 2008 Q4 | 28.45 Million CAD | -22.59% |
| 2008 Q3 | 36.76 Million CAD | 7.54% |
| 2008 Q2 | 34.18 Million CAD | 1.16% |
| 2008 Q1 | 33.79 Million CAD | -1.48% |
| 2008 FY | 25.04 Million CAD | -26.75% |
| 2007 Q3 | 14.92 Million CAD | -11.93% |
| 2007 Q1 | 18.52 Million CAD | 2.42% |
| 2007 FY | 34.18 Million CAD | 101.78% |
| 2007 Q4 | 34.3 Million CAD | 129.89% |
| 2007 Q2 | 16.94 Million CAD | -8.57% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q4 | 18.09 Million CAD | 3.34% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 FY | 16.94 Million CAD | 0.0% |
| 2006 Q3 | 17.5 Million CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.06 Million CAD | 89.257% |
| CanadaBis Capital Inc. | 7.3 Million CAD | 92.557% |
| Decibel Cannabis Company Inc. | 40.96 Million CAD | 98.672% |
| Delivra Health Brands Inc. | 2.02 Million CAD | 73.162% |
| Entourage Health Corp. | 161.58 Million CAD | 99.663% |
| Lifeist Wellness Inc. | 1.26 Million CAD | 57.031% |
| Cannara Biotech Inc. | 45.78 Million CAD | 98.812% |
| PharmaCielo Ltd. | 18.3 Million CAD | 97.029% |
| Rubicon Organics Inc. | 10.25 Million CAD | 94.698% |
| BioSyent Inc. | 1.22 Million CAD | 55.448% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -1260.0% |